ATE331958T1 - Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen - Google Patents
Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellenInfo
- Publication number
- ATE331958T1 ATE331958T1 AT03743923T AT03743923T ATE331958T1 AT E331958 T1 ATE331958 T1 AT E331958T1 AT 03743923 T AT03743923 T AT 03743923T AT 03743923 T AT03743923 T AT 03743923T AT E331958 T1 ATE331958 T1 AT E331958T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- tumour
- culture surface
- tumour markers
- specific
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0203136 | 2002-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE331958T1 true ATE331958T1 (de) | 2006-07-15 |
Family
ID=27799043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03743923T ATE331958T1 (de) | 2002-03-13 | 2003-03-13 | Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050079557A1 (de) |
EP (1) | EP1506407B1 (de) |
JP (1) | JP4256265B2 (de) |
AT (1) | ATE331958T1 (de) |
AU (1) | AU2003242815A1 (de) |
DE (1) | DE60306517T2 (de) |
ES (1) | ES2268387T3 (de) |
WO (1) | WO2003076942A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2846426B1 (fr) | 2002-10-28 | 2004-12-10 | Bio Merieux | Procede de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie |
EP1723428A2 (de) | 2004-02-19 | 2006-11-22 | Yale University Corporation | Identifizierung von krebsprotein-biomarkern unter verwendung von proteomtechniken |
PL1861509T3 (pl) * | 2005-03-14 | 2016-01-29 | Janssen Diagnostics Llc | Sposób predykcji przeżywalności bez progresji i przeżywalności całkowitej przy wizytach kontrolnych w trakcie terapii u pacjentów z rozsianym rakiem piersi wykorzystujący krążące komórki nowotworowe |
FR2896881B1 (fr) | 2006-01-31 | 2008-04-18 | Biomerieux Sa | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
WO2007106545A2 (en) * | 2006-03-13 | 2007-09-20 | Veridex, Llc | Propagation of primary cells |
EP2064552B1 (de) * | 2006-09-07 | 2011-08-31 | Universitätsklinikum Hamburg-Eppendorf | Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen |
GB0815675D0 (en) | 2008-08-28 | 2008-10-08 | Mabtech Ab | Antibody secreting cell elispot |
WO2012006421A2 (en) | 2010-07-07 | 2012-01-12 | The Regents Of The University Of Michigan | Diagnosis and treatment of breast cancer |
JP5804634B2 (ja) * | 2011-10-07 | 2015-11-04 | 久和 内山 | 植物栽培装置 |
WO2014117021A2 (en) | 2013-01-25 | 2014-07-31 | Xcell Biosciences, Inc. | Methods, compositions, kits, and systems for selective enrichment of target cells |
FR3001805B1 (fr) | 2013-02-01 | 2015-02-20 | Biomerieux Sa | Procede de detection d'un cancer colorectal |
CN106244553A (zh) * | 2015-10-22 | 2016-12-21 | 厦门人瑞生物医药科技有限公司 | 循环肿瘤细胞的分离和检测方法 |
FR3050212B1 (fr) | 2016-04-15 | 2020-09-25 | Chu Montpellier | Procede de detection et/ou de caracterisation de cellules tumorales et appareil associe |
JP2019158777A (ja) * | 2018-03-16 | 2019-09-19 | 東ソー株式会社 | 腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL121659A (en) * | 1996-10-25 | 2000-07-16 | Bayer Ag | Method for determining CPSA in a blood sample |
US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
KR100399475B1 (ko) * | 1998-02-12 | 2003-09-29 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 순환 중인 암세포의 신속하고 효과적인 분리 방법 및 이를위한 제제 |
-
2003
- 2003-03-13 JP JP2003575115A patent/JP4256265B2/ja not_active Expired - Lifetime
- 2003-03-13 WO PCT/FR2003/000806 patent/WO2003076942A2/fr active IP Right Grant
- 2003-03-13 AT AT03743923T patent/ATE331958T1/de not_active IP Right Cessation
- 2003-03-13 DE DE60306517T patent/DE60306517T2/de not_active Expired - Lifetime
- 2003-03-13 US US10/505,673 patent/US20050079557A1/en not_active Abandoned
- 2003-03-13 ES ES03743923T patent/ES2268387T3/es not_active Expired - Lifetime
- 2003-03-13 EP EP03743923A patent/EP1506407B1/de not_active Expired - Lifetime
- 2003-03-13 AU AU2003242815A patent/AU2003242815A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005527793A (ja) | 2005-09-15 |
US20050079557A1 (en) | 2005-04-14 |
WO2003076942A2 (fr) | 2003-09-18 |
JP4256265B2 (ja) | 2009-04-22 |
EP1506407B1 (de) | 2006-06-28 |
DE60306517T2 (de) | 2007-01-04 |
AU2003242815A1 (en) | 2003-09-22 |
AU2003242815A8 (en) | 2003-09-22 |
ES2268387T3 (es) | 2007-03-16 |
WO2003076942A3 (fr) | 2004-04-08 |
EP1506407A2 (de) | 2005-02-16 |
DE60306517D1 (de) | 2006-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mizutani et al. | Expression of somatostatin receptor (SSTR) subtypes (SSTR-1, 2A, 3, 4 and 5) in neuroendocrine tumors using real-time RT-PCR method and immunohistochemistry | |
Schnitt | Breast cancer in the 21st century: neu opportunities and neu challenges | |
Park et al. | Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use? | |
ATE331958T1 (de) | Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen | |
JP2009115817A (ja) | 膠芽腫の進行に関連する経路を試験するための方法及び材料 | |
US8178307B2 (en) | Methods and compositions for detection of lethal cell and uses thereof | |
EP1759010A2 (de) | Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors | |
Pillai et al. | Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model | |
Song et al. | Combined detection of HER2, Ki67, and GSTP1 genes on the diagnosis and prognosis of breast cancer | |
ATE545867T1 (de) | I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom | |
JP2012531612A5 (de) | ||
CN102472753A (zh) | 基于组蛋白macroH2A同工型预测癌症复发风险的诊断方法 | |
JP2008524230A5 (de) | ||
Wang et al. | Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance | |
Endo et al. | HER2 mutation status in Japanese HER2-positive breast cancer patients | |
WO2014185528A1 (ja) | Tk1タンパク質の発現が亢進した結腸直腸癌患者に対する治療効果予測方法 | |
WO2003068268A3 (en) | Treatment, diagnosis and imaging of disease | |
WO2009019366A3 (fr) | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal | |
JPWO2016143697A1 (ja) | Syt13、syt8、anos1発現量による胃癌腹膜播種の検査方法、検査キット、分子標的治療薬スクリーニング方法、及び治療薬 | |
Yau et al. | HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays | |
JP2014505866A (ja) | 甲状腺の癌様の変化を識別する方法、方法を具体化するためのキットおよび甲状腺の癌様の変化を識別するためのメタロチオネイン(mt)の使用 | |
KR101238196B1 (ko) | 대장암의 간 전이 진단용 조성물 및 그 용도 | |
Cherciu et al. | Targeted Confocal Laser Endomicroscopy (CLE) for the Assessment of Putative Cancer Stem Cell Markers in Colorectal cancer-A Pilot Study | |
Tanei et al. | High HER2 intratumoral heterogeneity is a predictive factor for poor prognosis in Early-stage and Locally Advanced HER2-positive Breast Cancer | |
Wu et al. | Correlation Between Drug Sensitivity Profiles of Ex Vivo Expanded Circulating Tumor Cells and Clinical Treatment Response in Pancreatic Ductal Adenocarcinoma Patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |